Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients

Overview[ - collapse ][ - ]

Purpose This is a clinical study comparing the physiologic effects of two hypertonic solutions (mannitol, hypertonic saline) with a particular emphasis on changes in cerebral blood flow in patients with intracranial hypertension following serious traumatic brain injury (TBI).
ConditionTraumatic Brain Injury
Intracranial Hypertension
InterventionDrug: Mannitol
Drug: Hypertonic Saline
PhasePhase 4
SponsorThe University of Texas Health Science Center at San Antonio
Responsible PartyThe University of Texas Health Science Center at San Antonio
ClinicalTrials.gov IdentifierNCT00125229
First ReceivedJuly 27, 2005
Last UpdatedJune 22, 2012
Last verifiedJune 2012

Tracking Information[ + expand ][ + ]

First Received DateJuly 27, 2005
Last Updated DateJune 22, 2012
Start DateAugust 2005
Estimated Primary Completion DateJune 2006
Current Primary Outcome MeasuresNot Provided
Current Secondary Outcome MeasuresNot Provided

Descriptive Information[ + expand ][ + ]

Brief TitleCerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients
Official TitleCerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients
Brief Summary
This is a clinical study comparing the physiologic effects of two hypertonic solutions
(mannitol, hypertonic saline) with a particular emphasis on changes in cerebral blood flow
in patients with intracranial hypertension following serious traumatic brain injury (TBI).
Detailed Description
This is a study comparing effects of two hypertonic solutions (mannitol, 6.4% hypertonic
saline) on intracranial hypertension, cerebral blood flow, serum/urine osmolarity in
patients with increased intracranial pressure caused by traumatic brain injury. The study
is conducted during first 72 hours after the injury without any interference with standard
medical treatment as performed at the institution. When the hypertonic solution is indicated
by caregiver, the study team is informed and performs a set of physiologic bedside
measurements including evaluation of cerebral blood flow and changes in plasma and urine
osmolarity. The study is noninvasive and the study protocol does not hamper, in any way,
standard care of treatment for these patients.
Study TypeObservational
Study PhasePhase 4
Study DesignObservational Model: Case-Only, Time Perspective: Prospective
Condition
  • Traumatic Brain Injury
  • Intracranial Hypertension
InterventionDrug: Mannitol
Drug: Hypertonic Saline
Study Arm (s)Not Provided

Recruitment Information[ + expand ][ + ]

Recruitment StatusTerminated
Estimated Enrollment10
Estimated Completion DateJune 2006
Estimated Primary Completion DateJune 2006
Eligibility Criteria
Inclusion Criteria:

- Patients with severe TBI (motor Glasgow Coma Scale [GCS] score < 5)

- Age > 18 years

- Health care provider indicated a treatment of intracranial hypertension using
hyperosmotic agent

Exclusion Criteria:

- Brain dead (GCS 3, fixed dilated pupils)

- Life-threatening systemic injuries (AIS > 4 in an organ system other than brain); AIS
= Abbreviated Injury Score

- Hypotension not responsive to fluid resuscitation and low doses of dopamine

- Clinical or imaging sign/suspicion for internal carotid artery injury
GenderBoth
Ages18 Years
Accepts Healthy VolunteersNo
ContactsNot Provided
Location CountriesUnited States

Administrative Information[ + expand ][ + ]

NCT Number NCT00125229
Other Study ID Numbers045-1503-266
Has Data Monitoring CommitteeNot Provided
Information Provided ByThe University of Texas Health Science Center at San Antonio
Study SponsorThe University of Texas Health Science Center at San Antonio
CollaboratorsNot Provided
Investigators Principal Investigator: Roman Hlatky, M.D. Center for Neurosurgical Sciences - UTHSC San Antonio
Verification DateJune 2012

Locations[ + expand ][ + ]

Center for Neurosurgery Sciences - UTHSCSA - Surgical Intensive Care Unit (SICU)
San Antonio, Texas, United States, 78229